Biotech

All Articles

Praxis epilepsy medicine lessens seizures in stage 2 hearing

.Practice Accuracy Medicines has actually scored another midphase win in epilepsy this year, with it...

Three execs resign as Dyne messages mixed data for DMD applicant

.After escaping a clinical hold several years back, Dyne Therapy has disclosed brand new phase 1/2 r...

Arrowhead fires off stage 3 data in uncommon metabolic health condition before market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own hand in advance of a potential face-off along with Ioni...

Pfizer, Valneva show lyme illness try reliable for second booster

.Pfizer and Valneva may have concerning 2 even more years to hang around prior to they produce the i...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a chat along with Ayla Ellison, Tough Biotech Editor-in-Chief and also Michelle B...

New data demonstrate how Bayer's asundexian failed to stop strokes

.Bayer put on hold the phase 3 test for its variable XIa inhibitor asundexian behind time in 2015 af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its various sclerosis (MS) med tolebrutinib to the FDA, e...

Galapagos' stock up as fund reveals intent to mold its own development

.Galapagos is actually happening under extra pressure from capitalists. Having actually created a 9....

Cell- concentrated Sana scoops first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings and...

Allist pays off Jacobio $21M, landing task in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has bought itself a starring job in China's KRAS market, spending J...